Crowdonomics
Frontier Bio Corp

Reg CF · SAFE · Mar 2026

ClosedReg CFSAFE
via WeFunder · last checked Aug 17, 2026
Raised
$0 / $1.2M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$1.3M
−$1.0M
FY2023
$1.4M
−$48K
FY2024
RevenueNet income
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$1,317,864
$1,394,414
Cost of goods sold
$1,090,182
$832,110
Gross margin
17%
40%
Net income
-$1,015,178
-$47,800
Taxes paid
$0
$0
Balance sheet
Cash
$662,239
$832,040
Accounts receivable
$0
$2,022
Total assets
$1,606,435
$1,669,618
Short-term debt
$808,325
$200,702
Long-term debt
$324,883
$189,747
Total liabilities
$1,133,208
$390,449
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$50,000
Max$1,235,000
Min investment—
OpenedMar 5, 2026
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active56

Links & provenance

Source: SEC EDGAR
0002107814-26-000001
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.